AETHLON MEDICAL INC — Form 8-K
Filed September 15, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 68/100
What the filing says
Aethlon Medical amended executive employment agreements for James B. Frakes (CEO/CFO) and Steven P. LaRosa, MD (CMO) effective September 11, 2026. The amendments require all severance payments and COBRA health insurance continuation payments to be paid as single lump sums upon a change of control, rather than in installments, with health care payments fixed and non-reducible regardless of subsequent coverage. No dollar amounts or specific benefit calculations are disclosed in the filing.
Why this rating
Change-of-control severance amendments for two senior executives is meaningful governance/risk event. Dollar amounts not specified, but typical for micro-cap firm (~$5.7M). Suggests M&A activity may be anticipated; material for company this size, though not immediately operationally transformational.
See more from September 15, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.